WALNUT CREEK, Calif. - November 22, 2021 - (Newswire.com) Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, will present its lead development candidate, AR-67, at this year's 5th Meridian Clinical Trials (MCT) conference, Nov. 22-23, 2021.